BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Medidata Solutions, Inc. Prices Initial Public Offering


6/25/2009 6:34:07 AM

NEW YORK--(BUSINESS WIRE)--Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced the pricing of its initial public offering of 6,300,000 shares of common stock at $14.00 per share. In addition, selling stockholders have granted the underwriters a 30-day option to purchase up to 945,000 shares of common stock at the initial public offering price to cover over-allotments, if any. Medidata’s common stock will commence trading on the NASDAQ Global Market on June 25, 2009, under the ticker symbol “MDSO.”

Citi and Credit Suisse Securities (USA) LLC acted as joint bookrunning managers for the proposed offering. Jefferies & Company, Inc. and Needham & Company, LLC acted as co-managers.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on June 24, 2009. Any offer or sale will be made only by means of a written prospectus forming part of the effective registration statement. A copy of the final prospectus may be obtained directly from:

Citi Brooklyn Army Terminal 140 58th Street, 8th Floor Brooklyn, N.Y. 11220 Telephone: (800) 831-9146 Telephone: (800) 221-1037

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in this offering, nor shall there be any sale, offer or solicitation of these securities in any state or jurisdiction in which such sale, offer or solicitation would be unlawful prior to registration or qualification under the securities laws of any state or jurisdiction.

Contact:

Investor Contact: Medidata Solutions Hulus Alpay, 212-419-1025 halpay@mdsol.com or Media Contact: Lois Paul & Partners Susan McCarron, 781-782-5767 susan_mccarron@lpp.com

Read at BioSpace.com
Read at Reuters

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES